Introduction to AI in Predicting Autoimmune Diseases
The Emergence of EXPRESSO
The advancement of artificial intelligence (AI) in the field of medical research has led to groundbreaking developments, particularly in the prediction and understanding of autoimmune…
What You Should Know:
– A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for…
Continue Reading
By Shania Kennedy
May 29, 2024 – A research team from Pennsylvania State University has developed an AI model to gain insight into how gene expression impacts autoimmune disease risk, according to a study published recently…
Continue Reading
In the search for faster and more effective medicines, the integration of artificial intelligence (AI) can positively impact millions of lives. AI is transforming the foundations of biotech, promising to alter precision medicine, clinical…
Continue Reading
We have developed a digital twin-based CKD identification and prediction model that leverages generalized metabolic fluxes (GMF) for patients with Type 2 Diabetes Mellitus (T2DM). GMF digital twins utilized basic clinical and physiological biomarkers…
Continue Reading
The coronary angiogram is the gold standard for evaluating the severity of coronary artery disease stenoses. Presently, the assessment is conducted visually by cardiologists, a method that lacks standardization. This study introduces DeepCoro, a…
Continue Reading
Generalization – the ability of AI systems to apply and/or extrapolate their knowledge to new data which might differ from the original training data – is a major challenge for the effective and responsible…
Continue Reading
Artificial intelligence-enabled electrocardiogram (ECG) algorithms are gaining prominence for the early detection of cardiovascular (CV) conditions, including those not traditionally associated with conventional ECG measures or expert interpretation. This study develops and validates such…
Continue Reading
What You Should Know:
– Implicity, a leader in remote patient monitoring and cardiac data management, has received FDA 510(k) clearance for SignalHF1, a groundbreaking new algorithm within their remote monitoring solution.
– SignalHF1 algorithm empowers…
Continue Reading
CU Medicine develops severe hypoglycemia predictive AI Researchers from the Faculty of Medicine at the Chinese University of Hong Kong (CU Medicine) have utilised anonymised big data from the Hospital Authority Data Collaboration Laboratory to…
Continue Reading
